Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial.
Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Kone AK, Guindo AB, Traore K, Sissoko M, Diallo DA, Diarra I, Kouriba B, Daou M, Dolo A, Baby M, Sissoko MS, Sagara I, Niangaly A, Traore I, Olotu A, Godeaux O, Leach A, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, Takala SL, Lyke KE, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV. Thera MA, et al. Among authors: heppner dg. PLoS One. 2010 Feb 4;5(2):e9041. doi: 10.1371/journal.pone.0009041. PLoS One. 2010. PMID: 20140214 Free PMC article. Clinical Trial.
Field trials of an asexual blood stage malaria vaccine: studies of the synthetic peptide polymer SPf66 in Thailand and the analytic plan for a phase IIb efficacy study.
Ballou WR, Blood J, Chongsuphajaissidhi T, Gordon DM, Heppner DG, Kyle DE, Luxemburger C, Nosten F, Sadoff JC, Singhasivanon P, et al. Ballou WR, et al. Among authors: heppner dg. Parasitology. 1995;110 Suppl:S25-36. doi: 10.1017/s0031182000001463. Parasitology. 1995. PMID: 7784126 Clinical Trial.
Phase I safety and immunogenicity testing of clinical lots of the synthetic Plasmodium falciparum vaccine SPf66 produced under good manufacturing procedure conditions in the United States.
Gordon DM, Duffy PE, Heppner DG, Lyon JA, Williams JS, Scheumann D, Farley L, Stacey D, Haynes JD, Sadoff JC, Ballou WR. Gordon DM, et al. Among authors: heppner dg. Am J Trop Med Hyg. 1996 Jul;55(1):63-8. doi: 10.4269/ajtmh.1996.55.63. Am J Trop Med Hyg. 1996. PMID: 8702024 Clinical Trial.
SPf66 malaria vaccine is safe and immunogenic in malaria naive adults in Thailand.
Migasena S, Heppner DG, Kyle DE, Chongsuphajaisiddhi T, Gordon DM, Suntharasamai P, Permpanich B, Brockman A, Pitiuttutham P, Wongsrichanalai C, Srisuriya P, Phonrat B, Pavanand K, Viravan C, Ballou WR. Migasena S, et al. Among authors: heppner dg. Acta Trop. 1997 Sep 30;67(3):215-27. doi: 10.1016/s0001-706x(97)00061-2. Acta Trop. 1997. PMID: 9241386 Clinical Trial.
Malaria vaccines: triumphs or tribulations?
Ballou WR, Kester KE, Stoute JA, Heppner DG. Ballou WR, et al. Among authors: heppner dg. Parassitologia. 1999 Sep;41(1-3):403-8. Parassitologia. 1999. PMID: 10697893 Review.
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.
Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Krzych U, Delchambre M, Voss G, Dowler MG, Palensky J, Wittes J, Cohen J, Ballou WR; RTS,S Malaria Vaccine Evaluation Group. Kester KE, et al. Among authors: heppner dg. J Infect Dis. 2001 Feb 15;183(4):640-7. doi: 10.1086/318534. Epub 2001 Jan 24. J Infect Dis. 2001. PMID: 11170991 Clinical Trial.
120 results